The current utility of oligonucleotide aptamers in targeting the MUC1 mucin tumour marker

Simple item page
dc.contributor.advisorLimson, Janice
dc.contributor.advisorFogel, Ronen
dc.contributor.authorFlanagan, Shane Patrick
dc.date.accessioned2026-03-04T15:32:15Z
dc.date.issued2018
dc.description.abstractExpected release date-April 2020
dc.description.degreeDoctoral thesis
dc.description.degreePhD
dc.format.mimetypeapplication/pdf
dc.identifier.otherhttp://hdl.handle.net/10962/62969
dc.identifier.urihttps://researchrepository.ru.ac.za/handle/123456789/8169
dc.languageEnglish
dc.publisherRhodes University, Faculty of Science, Biotechnology Innovation Centre
dc.rightsFlanagan, Shane Patrick,Restricted access-thesis embargoed for 2 years
dc.subjectUncatalogued
dc.titleThe current utility of oligonucleotide aptamers in targeting the MUC1 mucin tumour marker
dc.typeAcademic thesis

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
The_current_utility_of_oligonucleotide_aptamers_in_vital_28348.pdf
Size:
631.99 KB
Format:
Adobe Portable Document Format
Download

Collections

Doctoral Degrees (RUBIC)